Further, the count of CCR2+ PBMCs and CCR2 mRNA transcript in PBMCs was significantly lower in severe and moderate ALS as compared to ALS patients with mild impairments. This evidence concerns the gene CCR2 and amyotrophic lateral sclerosis.